Laboratory Research Technician – Cell Culture & Immunology
As a Laboratory Research Technician, you will support the mission-critical daily research activities that keep our TCR-T cell programs moving forward.
Pan Cancer T are EIT Health Catapult Finalists
June 10, 2024
On 5th June, our CEO, Rachel Abbott, was pleased to represent Pan Cancer T in the EIT Health Catapult finals at the health.tech global summit in Munich. This marks the culmination of the EIT Health Catapult program, a unique competition and training programme that fast-tracks Europe’s best life sciences and health tech start-ups and showcases them to leading experts and investors across Europe. Throughout the programme, start-ups receive intensive training in business modelling and planning, investment deal negotiation, and pitch preparation as they build their credibility and visibility through pan-European exposure, before pitching their service or product to international investors and world-leading companies.
Other news
Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer
Pan Cancer T has secured EUR 10 million to move its TCR T cell therapy for triple negative breast cancer into first-in-human trials
Pan Cancer T announces that Dr. Helen Tayton-Martin has joined its board as an independent director
Dr. Helen Tayton-Martin joins our board, bringing decades of leadership in TCR-T cell therapy and biotech growth.